Skip to main content
OpenTrials

Clinical trial condition

Peritoneal Cancer

Explore clinical trials studying Peritoneal Cancer. Study availability and eligibility vary by location and protocol.

104 public trials 17 recruiting studies
Refine in advanced search Browse all conditions

Peritoneal Cancer trial results

Completed

Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR

NCT04295577

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Royal United Hospitals Bath Bath, United Kingdom
  • Belfast Health & Social Care Trust Belfast, United Kingdom
  • University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom
  • University Hospitals Bristol NHS Foundation Trust Bristol, United Kingdom
View all 15 locations
View Trial Details
Completed

Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers

NCT05041257

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • City of Hope National Medical Center /ID# 269928 Duarte, California, United States
  • University of California Los Angeles /ID# 269969 Los Angeles, California, United States
  • University Colorado Cancer Center /ID# 269930 Aurora, Colorado, United States
  • Women'S Cancer Care /ID# 269925 Covington, Louisiana, United States
View all 35 locations
View Trial Details
Completed

Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT01767675

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States
  • Baptist Health South Florida Miami, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Completed

A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression

NCT04296890

Conditions
Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +21 more
Locations
  • Arizona Oncology Associates Phoenix, Arizona, United States
  • City of Hope Medical Center Duarte, California, United States
  • California Cancer Associates (cCARE) Fresno, California, United States
  • Stanford School of Medicine Palo Alto, California, United States
View all 89 locations
View Trial Details

Related conditions